Skip to main content
PMC home page
Molecular Medicine logoLink to Molecular Medicine
. 1999 Dec;5(12):806–811.

Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease.

A K Topaloglu 1, G A Ashley 1, B Tong 1, J Shabbeer 1, K H Astrin 1, C M Eng 1, R J Desnick 1
PMCID: PMC2230489  PMID: 10666480

Abstract

BACKGROUND: Fabry disease, an X-linked inborn error of glycosphingolipid catabolism, results from the deficient activity of the lysosomal exoglycohydrolase alpha-galactosidase A (EC 3.2.1.22; alpha-Gal A). The nature of the molecular lesions in the alpha-Gal A gene in 30 unrelated families was determined to provide precise heterozygote detection, prenatal diagnosis, and define genotype-phenotype correlations. MATERIALS AND METHODS: Genomic DNA was isolated from affected males and/or carrier females from 30 unrelated families with Fabry disease. The entire alpha-Gal A coding region and flanking intronic sequences were analyzed by PCR amplification and automated sequencing. RESULTS: Twenty new mutations were identified, each in a single family: C142R, G183D, S235C, W236L, D244H, P259L, M267I, I289F, Q321E, C378Y, C52X, W277X, IVS4(+4), IVS6(+2), IVS6(-1), 35del13, 256del1, 892ins1, 1176del4, and 1188del1. In the remaining 10 unrelated Fabry families, 9 previously reported mutations were detected: M42V, R112C, S148R, D165V, N215S (in 2 families), Q99X, C142X, R227X, and 1072del3. Haplotype analysis using markers closely flanking the alpha-Gal A gene indicated that the two patients with the N215S lesion were unrelated. The IVS4(+4) mutation was a rare intronic splice site mutation that causes Fabry disease. CONCLUSIONS: These studies further define the heterogeneity of mutations in the alpha-Gal A gene causing Fabry disease, permit precise heterozygote detection and prenatal diagnosis, and help delineate phenotype-genotype correlations in this disease. </AB

Full text

PDF
808

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bishop D. F., Calhoun D. H., Bernstein H. S., Hantzopoulos P., Quinn M., Desnick R. J. Human alpha-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4859–4863. doi: 10.1073/pnas.83.13.4859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Caggana M., Ashley G. A., Desnick R. J., Eng C. M. Fabry disease: molecular carrier detection and prenatal diagnosis by analysis of closely linked polymorphisms at Xq22.1. Am J Med Genet. 1997 Aug 22;71(3):329–335. [PubMed] [Google Scholar]
  3. Cooper D. N., Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet. 1988 Feb;78(2):151–155. doi: 10.1007/BF00278187. [DOI] [PubMed] [Google Scholar]
  4. Desnick R. J., Allen K. Y., Desnick S. J., Raman M. K., Bernlohr R. W., Krivit W. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med. 1973 Feb;81(2):157–171. [PubMed] [Google Scholar]
  5. Eng C. M., Ashley G. A., Burgert T. S., Enriquez A. L., D'Souza M., Desnick R. J. Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes. Mol Med. 1997 Mar;3(3):174–182. [PMC free article] [PubMed] [Google Scholar]
  6. Eng C. M., Desnick R. J. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Hum Mutat. 1994;3(2):103–111. doi: 10.1002/humu.1380030204. [DOI] [PubMed] [Google Scholar]
  7. Eng C. M., Niehaus D. J., Enriquez A. L., Burgert T. S., Ludman M. D., Desnick R. J. Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene. Hum Mol Genet. 1994 Oct;3(10):1795–1799. doi: 10.1093/hmg/3.10.1795. [DOI] [PubMed] [Google Scholar]
  8. Eng C. M., Resnick-Silverman L. A., Niehaus D. J., Astrin K. H., Desnick R. J. Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease. Am J Hum Genet. 1993 Dec;53(6):1186–1197. [PMC free article] [PubMed] [Google Scholar]
  9. Kornreich R., Astrin K. H., Desnick R. J. Amplification of human polymorphic sites in the X-chromosomal region q21.33 to q24: DXS17, DXS87, DXS287, and alpha-galactosidase A. Genomics. 1992 May;13(1):70–74. doi: 10.1016/0888-7543(92)90203-5. [DOI] [PubMed] [Google Scholar]
  10. Kornreich R., Desnick R. J., Bishop D. F. Nucleotide sequence of the human alpha-galactosidase A gene. Nucleic Acids Res. 1989 Apr 25;17(8):3301–3302. doi: 10.1093/nar/17.8.3301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sakuraba H., Oshima A., Fukuhara Y., Shimmoto M., Nagao Y., Bishop D. F., Desnick R. J., Suzuki Y. Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. Am J Hum Genet. 1990 Nov;47(5):784–789. [PMC free article] [PubMed] [Google Scholar]
  12. von Scheidt W., Eng C. M., Fitzmaurice T. F., Erdmann E., Hübner G., Olsen E. G., Christomanou H., Kandolf R., Bishop D. F., Desnick R. J. An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med. 1991 Feb 7;324(6):395–399. doi: 10.1056/NEJM199102073240607. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES